New Journal: GM Crops
News Sep 25, 2009
We believe that this is an excellent time to start the journal because of the increasing focus on GM crops and improved agronomic traits. Genetic engineering techniques and applications have developed rapidly since the introduction of the first genetically modified plants in the 1980s. There has been a rapid increase in GM crop R&D by academia, government and industry around the world. GM crops are useful to consumers, farmers and the environment, and are growing in popularity worldwide.
GM crops are needed to tackle the food needs of a growing population. Crops with improved agronomic characteristics can provide protection against many of the biotic stresses caused by weeds, pests, and diseases currently experienced in developing countries. Also, GM crop R&D is focused on the development of more complex traits, such as drought resistance and the development of foods with enhanced nutritional value which may provide a low-cost way of dealing with widespread malnutrition problems.
Because GM crops can address key challenges in the food and agricultural sector, it is expected that the number of GM crops ready for commercial release in many countries will expand considerably over the next few years. Genetic modification is a tool integrated into a wider research agenda, where public and private science can balance each other. Scientists in both the public and private sectors regard the GM process as a major new set of tools to improve crop traits, while industry regards it as an opportunity for increased profits. Genetically modified crop varieties allegedly provide farmers with various agronomic benefits, but serious environmental, health and ethical concerns also are being raised.
Back in 2009, researchers identified a herd of Awassi sheep suffering from "day blindness". As that term implies, these sheep were blind during the day (in bright light) but could see at night, in low-light conditions. After identifying the genetic basis of this blindness, researchers have now successfully used gene therapy to restore their daytime vision.READ MORE
The National Institutes of Health announced the launch of a new initiative to help speed the development of cures for sickle cell disease. The Cure Sickle Cell Initiative will take advantage of the latest genetic discoveries and technological advances to move the most promising genetic-based curative therapies safely into clinical trials within five to 10 years.